IGC
IGC Pharma, Inc.
+0.00 (+0.74%)0.27USD232K成交股數28.1M市值–本益比(近四季)25.5股價營收比-19.2%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 265K-20% | 317K+23% | 191K-54% | 328K+21% | 330K+12% | 257K+26% | 412K+42% | 272K-51% | 295K | 204K | 291K | 555K |
| 營業成本 | 217K | 262K | 92K | 174K | 176K | 153K | 214K | 109K | 124K | 71K | 117K | 300K |
| 毛利 | 48K-69% | 55K-47% | 99K-50% | 154K-6% | 154K-10% | 104K-22% | 198K+14% | 163K-36% | 171K | 133K | 174K | 255K |
| 毛利率 | 18.1% | 17.4% | 51.8% | 47.0% | 46.7% | 40.5% | 48.1% | 59.9% | 58.0% | 65.2% | 59.8% | 45.9% |
| 研發費用 | 1.4M | 1.3M | 1.6M | 851K | 997K | 852K | 917K | 889K | 855K | 903K | 1.3M | 747K |
| 銷售管理費用 | 1.4M | 1.2M | 1.4M | 1.2M | 570K | 1.1M | 1.0M | 1.7M | 1.5M | 2.2M | 1.4M | 1.6M |
| 營業利益 | −2.8M+97% | −2.5M+31% | −2.9M+65% | −1.9M-20% | −1.4M-35% | −1.9M-37% | −1.8M-29% | −2.4M+12% | −2.2M | −3.0M | −2.5M | −2.1M |
| 營業利益率 | -1,050.6% | -775.4% | -1,517.8% | -580.8% | -428.2% | -730.7% | -427.2% | -880.9% | -735.6% | -1,469.6% | -856.0% | -385.4% |
| 稅後淨利 | −2.9M+145% | −2.4M+31% | −1.8M+6% | −1.6M-33% | −1.2M-58% | −1.8M-67% | −1.7M-30% | −2.4M+15% | −2.9M | −5.6M | −2.5M | −2.1M |
| 淨利率 | -1,107.9% | -757.7% | -953.4% | -487.5% | -363.0% | -711.7% | -416.7% | -874.3% | -978.0% | -2,739.7% | -842.3% | -373.9% |
| 稀釋 EPS | -0.03+50% | -0.020% | -0.020% | -0.02-33% | -0.02 | -0.02-78% | -0.02-60% | -0.03 | – | -0.09 | -0.05 | – |
| 稀釋股數 | 100M | 98.2M | 90.5M | 83.0M | 79.7M | 77.6M | 76.0M | 72.8M | 58.8M | 63.7M | 54.3M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 331K | 207K | 1.1M | 454K | 405K | 470K | 1.5M | 1.8M | 1.2M | 1.4M | 3.0M | 1.7M |
| 應收帳款 | 56K | 37K | 41K | 87K | 34K | 49K | 44K | 28K | 39K | 92K | 137K | 225K |
| 存貨 | 640K | 638K | 658K | 1.3M | 1.4M | 1.4M | 1.5M | 1.5M | 1.5M | 1.9M | 2.6M | 2.6M |
| 總資產 | 9.5M | 9.2M | 9.7M | 7.9M | 8.7M | 9.1M | 10.4M | 10.6M | 9.9M | 11.3M | 16.5M | 15.7M |
| 有息負債 | – | – | 132K | 133K | 134K | 134K | 135K | 136K | 137K | 138K | 139K | 140K |
| 總負債 | 3.4M | 3.1M | 1.7M | 1.9M | 2.4M | 2.8M | 3.0M | 2.7M | 2.6M | 2.2M | 2.4M | 2.5M |
| 股東權益 | 6.1M | 6.1M | 8.1M | 6.1M | 6.3M | 6.3M | 7.4M | 7.9M | 7.3M | 9.1M | 14.1M | 13.2M |
| 負債比 | 35.4% | 33.4% | 16.9% | 23.5% | 27.6% | 31.1% | 28.9% | 25.6% | 26.1% | 19.6% | 14.6% | 15.8% |
| 淨現金(現金 − 有息負債) | – | – | 973K | 321K | 271K | 336K | 1.4M | 1.7M | 1.1M | 1.2M | 2.9M | 1.6M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.2M | – | −1.4M-20% | −730K | – | – | −1.8M+19% | – | – | – | −1.5M |
| 資本支出 | – | 1K | – | 8K | 18K | – | – | 38K | – | – | – | 20K |
| 自由現金流 | – | −1.2M | – | −1.4M-21% | −748K | – | – | −1.8M+20% | – | – | – | −1.5M |
| 折舊攤銷 | – | 58K | – | 141K | 154K | – | – | 162K | – | – | – | 155K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -386.1% | – | -431.4% | -226.7% | – | – | -658.1% | – | – | – | -268.1% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 1.3M
| 美國 | 1.3M | 99.8% | +7.6% |
|---|---|---|---|
| CO | 2K | 0.2% | 0.0% |
產品／服務2025 年度 · 2.6M
| White Labeling Services | 1.2M | 44.7% | – |
|---|---|---|---|
| Tolling White Labeling Service | 1.2M | 44.7% | +21.5% |
| Infrastructure | 164K | 6.3% | – |
| Wellness And Lifestyle | 113K | 4.4% | -50.4% |
| Life Sciences 小計 | 1.3M | 49.0% | – |
| Plant And Cannabinoid 小計 | 1.3M | 49.0% | -5.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.3M | -5.5% | −7.1M | -560.3% | -0.09 | −4.9M |
| FY2024 | 1.3M | +47.6% | −13.0M | -966.5% | -0.22 | −5.3M |
| FY2023 | 911K | +129.5% | −11.5M | -1,263.0% | – | −7.4M |
| FY2022 | 397K | -55.8% | −15.0M | -3,782.4% | – | −7.7M |
| FY2021 | 898K | -77.9% | −8.8M | -981.2% | -0.21 | −12.3M |
| FY2020 | 4.1M | -20.4% | −7.3M | -179.6% | -0.19 | −13.1M |
| FY2019 | 5.1M | – | −4.1M | -80.1% | -0.13 | −3.3M |